LG 5

The New Endocrine System: Rethinking Physiology Beyond Classical Glands

Speaker Information

  • Presenter: Dr. Nazleen Shakir Akreyi
  • Profession: Family Physician, Physiologist
  • Event: UG3, December 2025
  • Contact: nazleen.shakir@hmu.edu.krd

Learning Objectives

By the end of this session, students should be able to:

  • Define classical versus new endocrine organs.
  • Describe new hormones and their functions.
  • Recognize organ cross-talk and integration within the endocrine system.
  • Relate the discoveries in modern endocrinology to clinical practice.
  • Appreciate the evolving concepts shaping modern endocrinology.

Defining an Endocrine Organ

  • Question: What defines an "Endocrine organ"?
  • Traditionally, the definition revolved around classical endocrine glands; however, new research indicates
    that many body tissues meet the definition of endocrine organs.

Every Tissue Talks

  • Examples of Tissues Exhibiting Endocrine Function:
    • Gut
    • Adipose Tissue
    • Bone
    • Muscle

Emerging Endocrine Molecules

  • Key Categories of Emerging Endocrine Molecules and Their Functions:
    • Adipokines:
    • Leptin: Regulates appetite and energy balance, improves insulin sensitivity, has anti-inflammatory effects.
    • Adiponectin: Enhances insulin sensitivity and reduces inflammation.
    • Myokines:
    • Irisin: Released during muscle contractions; stimulates metabolism and glucose uptake.
    • Myostatin: Inhibits muscle growth and is involved in the regulation of muscle mass.
    • Osteokines:
    • Osteocalcin: Involved in bone formation; regulates glucose metabolism and male fertility.
    • FGF23: Regulates phosphate homeostasis and vitamin D metabolism.
    • Gut Hormones:
    • GLP-1 (Glucagon-like peptide-1): Stimulates insulin secretion, suppresses appetite, slows gastric emptying.
    • Ghrelin: Stimulates hunger and regulates energy balance.
    • PYY (Peptide YY): Inhibits appetite.
    • Cardiac Hormones:
    • Atrial Natriuretic Peptide (ANP) and B-type Natriuretic Peptide (BNP): Regulate blood pressure and fluid balance; involved in cardiac remodeling.

Adipose Tissue as an Endocrine Organ

  • Key Molecules:
    • Leptin and Adiponectin are secreted from adipose tissue.
  • Functions:
    • Regulate energy balance and improve insulin sensitivity.

Gut as Endocrine Organ

  • Key Molecules: GLP-1, GIP (Gastric Inhibitory Peptide), Ghrelin.
  • Functions:
    • GLP-1 and GIP enhance insulin release when glucose is present, stimulate satiety, and slow gastric emptying.

Heart as Endocrine Organ

  • Key Molecules: ANP, BNP, CNP (C-type Natriuretic Peptide).
  • Functions:
    • Regulate blood pressure and fluid balance; respond to increased cardiac workload.

Bone as Endocrine Organ

  • Key Molecules: Osteocalcin, FGF23.
  • Functions:
    • Regulate muscle growth, glucose metabolism, and phosphate homeostasis.

Muscle as Endocrine Organ

  • Key Molecules: Irisin, Myostatin.
  • Functions:
    • Involved in energy expenditure, muscle growth, glucose uptake, and promoting endothelial function.

Immune-Endocrine Interaction

  • Cyclic interactions between the endocrine system, immune system, and central nervous system influence metabolism and health.
  • Key Players: Neurotransmitters, Cytokines (e.g., IL-6), and hormones (e.g., Prolactin, Oxytocin).

Organ Hormone Relationships

  • Details of Specific Organ Hormones and Functions:
    • Adipose Tissue: Leptin, adiponectin; regulates energy balance, associated with obesity and metabolic syndrome.
    • Gut: GLP-1, GIP, Ghrelin, PYY; appetite regulation, insulin release, satiety involved in diabetes and obesity management.
    • Heart: ANP, BNP; important for fluid and blood pressure regulation, used in diagnosing heart failure.
    • Bone: Osteocalcin, FGF23; regulates glucose metabolism and phosphate homeostasis, relevant in osteoporosis and chronic kidney disease.
    • Muscle: Irisin, Myostatin; important in exercise physiology and energy expenditure regulation.
    • Immune System: Cytokines as endocrine mediators; involved in chronic inflammation and metabolic disorders.

Mini Case Studies

Case 1: GLP-1 Therapy
  • Patient Profile: 45-year-old male with obesity and Type 2 Diabetes Mellitus (T2DM) on GLP-1 agonist losing 12 kg.
  • Physiological Mechanisms of GLP-1:
    • Appetite Suppression: GLP-1 binds to receptors in the CNS leading to increased satiety and reduced food intake.
    • Gastric Emptying: Slows gastric emptying, moderating postprandial glucose spikes.
    • Insulin Regulation: Enhances insulin secretion and suppresses glucagon release in a glucose-dependent manner.
  • Outcomes: Continued therapy results in sustained effects; weight regain common after stopping therapy.
Case 2: Cardiac Function Assessment via BNP
  • Patient Profile: 68-year-old patient with shortness of breath, BNP level of 800 pg/mL.
  • Interpretation of BNP Levels:
    • Elevated BNP indicates significant cardiac dysfunction, particularly heart failure.
    • Higher BNP correlates with heart failure severity; >500 pg/mL suggestive of heart failure.
    • Also used in monitoring treatment response; levels decrease with effective management.
  • Caveat: Elevated BNP may also arise from non-cardiac conditions; clinical context is crucial.

New Therapies Evolving from Physiology

  • GLP-1 Analogues: Used in the management of diabetes and obesity.
  • SGLT2 Inhibitors: Impact cardio-renal outcomes, initially developed for diabetes management but beneficial for heart failure.
    • Mechanism: Block sodium-glucose cotransporter 2, promoting glucose excretion.
    • Benefits: Reduce hospitalizations for heart failure and cardiovascular deaths.
    • Examples: Dapagliflozin, Empagliflozin, Canagliflozin.
  • Leptin Analogues: Treatment for congenital leptin deficiency.
  • FGF23 Targeting: Management of chronic kidney disease associated with mineral bone disorder.

Summary & Take-Home Messages

  • The endocrine system functions as a network rather than a strictly hierarchical structure.
  • Emerging endocrine roles involve fat, gut, bone, muscle, heart, and immune cells.
  • Clinical relevance expands into metabolic and chronic diseases.
  • Future directions suggest a shift towards personalized and integrative endocrinology.